202 related articles for article (PubMed ID: 31005226)
1. Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk.
Loi M; Magallon-Baro A; Suker M; van Eijck C; Sharma A; Hoogeman M; Nuyttens J
Radiother Oncol; 2019 May; 134():67-73. PubMed ID: 31005226
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
[TBL] [Abstract][Full Text] [Related]
3. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR).
Kim M; Schiff JP; Price A; Laugeman E; Samson PP; Kim H; Badiyan SN; Henke LE
Radiat Oncol; 2022 Sep; 17(1):157. PubMed ID: 36100866
[TBL] [Abstract][Full Text] [Related]
4. Interfraction Anatomical Variability Can Lead to Significantly Increased Rectal Dose for Patients Undergoing Stereotactic Body Radiotherapy for Prostate Cancer.
Wahl M; Descovich M; Shugard E; Pinnaduwage D; Sudhyadhom A; Chang A; Roach M; Gottschalk A; Chen J
Technol Cancer Res Treat; 2017 Apr; 16(2):178-187. PubMed ID: 27199276
[TBL] [Abstract][Full Text] [Related]
5. A model-based patient selection tool to identify who may be at risk of exceeding dose tolerances during pancreatic SBRT.
Magallon-Baro A; Granton PV; Milder MTW; Loi M; Zolnay AG; Nuyttens JJ; Hoogeman MS
Radiother Oncol; 2019 Dec; 141():116-122. PubMed ID: 31606227
[TBL] [Abstract][Full Text] [Related]
6. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
[TBL] [Abstract][Full Text] [Related]
7. Assessment of interfraction dose variation in pancreas SBRT using daily simulation MR images.
Young T; Lee M; Johnston M; Nguyen T; Ko R; Arumugam S
Phys Eng Sci Med; 2023 Dec; 46(4):1619-1627. PubMed ID: 37747645
[TBL] [Abstract][Full Text] [Related]
8. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.
Henke L; Kashani R; Yang D; Zhao T; Green O; Olsen L; Rodriguez V; Wooten HO; Li HH; Hu Y; Bradley J; Robinson C; Parikh P; Michalski J; Mutic S; Olsen JR
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1078-1086. PubMed ID: 27742541
[TBL] [Abstract][Full Text] [Related]
9. Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer.
Schiff JP; Price AT; Stowe HB; Laugeman E; Chin RI; Hatscher C; Pryser E; Cai B; Hugo GD; Kim H; Badiyan SN; Robinson CG; Henke LE
Radiother Oncol; 2022 Oct; 175():144-151. PubMed ID: 36063981
[TBL] [Abstract][Full Text] [Related]
10. Characterization and management of interfractional anatomic changes for pancreatic cancer radiotherapy.
Liu F; Erickson B; Peng C; Li XA
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e423-9. PubMed ID: 22436785
[TBL] [Abstract][Full Text] [Related]
11. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
[TBL] [Abstract][Full Text] [Related]
12. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
14. Dynamic simulation of motion effects in IMAT lung SBRT.
Zou W; Yin L; Shen J; Corradetti MN; Kirk M; Munbodh R; Fang P; Jabbour SK; Simone CB; Yue NJ; Rengan R; Teo BK
Radiat Oncol; 2014 Nov; 9():225. PubMed ID: 25365935
[TBL] [Abstract][Full Text] [Related]
15. Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy.
Bohoudi O; Bruynzeel AME; Meijerink MR; Senan S; Slotman BJ; Palacios MA; Lagerwaard FJ
Radiother Oncol; 2019 Mar; 132():16-22. PubMed ID: 30825964
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Daily Online Plan Adaptation Strategies for a Cohort of Pancreatic Cancer Patients Treated with SBRT.
Magallon-Baro A; Milder MTW; Granton PV; Nuyttens JJ; Hoogeman MS
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):208-219. PubMed ID: 33811976
[TBL] [Abstract][Full Text] [Related]
17. In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiation Therapy (CT-STAR) for the Treatment of Abdominal Oligometastases.
Schiff JP; Stowe HB; Price A; Laugeman E; Hatscher C; Hugo GD; Badiyan SN; Kim H; Robinson CG; Henke LE
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):1022-1031. PubMed ID: 35768023
[TBL] [Abstract][Full Text] [Related]
18. MRI guided stereotactic radiotherapy for locally advanced pancreatic cancer.
Heerkens HD; van Vulpen M; Erickson B; Reerink O; Intven MP; van den Berg CA; Molenaar IQ; Vleggaar FP; Meijer GJ
Br J Radiol; 2018 Nov; 91(1091):20170563. PubMed ID: 30063383
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric effect of the intestinal gas of online adaptive stereotactic body radiotherapy on target and critical organs without online electron density correction for pancreatic cancer.
Su C; Okamoto H; Nishioka S; Sakasai T; Fujiyama D; Miura Y; Tsunoda Y; Kuwahara J; Nakamura S; Iijima K; Chiba T; Kaga K; Takemori M; Nakayama H; Katsuta S; Inaba K; Igaki H; Nakayama Y; Itami J
Br J Radiol; 2021 Mar; 94(1119):20200239. PubMed ID: 33353402
[TBL] [Abstract][Full Text] [Related]
20. Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model.
Nakamura A; Prichard HA; Wo JY; Wolfgang JA; Hong TS
J Appl Clin Med Phys; 2019 Feb; 20(2):71-83. PubMed ID: 30636367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
